Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

PLSE - Pulse Biosciences Inc Stock Price, Fair Value and News

$17.09+0.24 (+1.42%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

PLSE Price Action

Last 7 days

-1.5%

Last 30 days

16.8%

Last 90 days

-22.4%

Trailing 12 Months

145.1%

PLSE Stock Price

PLSE RSI Chart

AugSepOctNovDec2025FebMarAprMay102030405060708090

PLSE Valuation

Market Cap

1.1B

Price/Earnings (Trailing)

-18.88

Price/Sales (Trailing)

1.6K

EV/EBITDA

-17.03

Price/Free Cashflow

-28.26

PLSE Price/Sales (Trailing)

202220232024202505001K1.5K2K

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PLSE Fundamentals

PLSE Revenue

Revenue (TTM)

700.0K

202020212022202320242025500K1M1.5M2M

PLSE Earnings

Earnings (TTM)

-60.2M

Earnings Growth (Yr)

-65.68%

Earnings Growth (Qtr)

13.36%

20162018202020222024-60M-50M-40M-30M-20M-10M0

PLSE Profitability

Operating Margin

100.00%

EBT Margin

-8606.14%

Return on Equity

-50.86%

Return on Assets

-45.17%

Free Cashflow Yield

-3.54%

PLSE Investor Care

Shares Dilution (1Y)

21.82%

Revenue Breakdown

As of: Dec 31, 2022
Oct2022AprJul0100K200K300K400K500K
System Products
ProductValuePercent
GeographyValuePercent
TotalValuePercent

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20250000
20240000
20230000
20221.9M2.1M1.6M700.0K
202100682.0K1.4M
20200607.0K326.0K0
20190000
Get all data in R, Python etc through our Historical Stock Data APIs

About Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.
 WEBSITEpulsebiosciences.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES61

Pulse Biosciences Inc Frequently Asked Questions

What is the ticker symbol for Pulse Biosciences Inc? What does PLSE stand for in stocks?

PLSE is the stock ticker symbol of Pulse Biosciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Pulse Biosciences Inc (PLSE)?

As of Thu May 08 2025, market cap of Pulse Biosciences Inc is 1.14 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PLSE stock?

You can check PLSE's fair value in chart for subscribers.

Is Pulse Biosciences Inc a good stock to buy?

The fair value guage provides a quick view whether PLSE is over valued or under valued. Whether Pulse Biosciences Inc is cheap or expensive depends on the assumptions which impact Pulse Biosciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PLSE.

What is Pulse Biosciences Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 08 2025, PLSE's PE ratio (Price to Earnings) is -18.88 and Price to Sales (PS) ratio is 1.63 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PLSE PE ratio will change depending on the future growth rate expectations of investors.